NewGenIvf Group Ltd Class A(NIVF US)
$0.23-0.0516.44%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M09/30/2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.1 | 5.4 | 4.7 | 5.5 | ||||
| -Cost of Revenue | 3.5 | 3.6 | 3.8 | 4.0 | ||||
| Gross Profit | 1.7 | 1.8 | 1.0 | 1.5 | ||||
| -Operating Expenses | 1.6 | 3.0 | 11.7 | 6.0 | ||||
| +Selling, General & Admin | 1.6 | 3.0 | 11.7 | 6.0 | ||||
| +General And Administrative Expenses | 1.6 | 2.8 | 10.5 | 4.4 | ||||
| +Selling And Marketing Expenses | 0.0 | 0.2 | 1.2 | 0.3 | ||||
| +Research and Development | - | - | - | - | ||||
| +Other Operating Expenses | - | - | - | - | ||||
| Operating Income | 0.0 | -1.2 | -10.7 | -4.7 | ||||
| +Non Operating Income | 0.0 | -0.6 | 19.8 | 19.1 | ||||
| +Interest Income, Net | -0.0 | -0.8 | -0.6 | -0.7 | ||||
| +Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | ||||
| -Interest Expense | 0.0 | 0.8 | 0.6 | 0.7 | ||||
| +Other Non-Op Income | 0.1 | 0.2 | 20.5 | 19.9 | ||||
| Pretax Income | 0.1 | -1.0 | 9.7 | 15.2 | ||||
| -Income Tax Expense | - | -0.5 | - | -0.5 | ||||
| Income from Cont Ops | 0.1 | -0.5 | 9.7 | 15.7 | ||||
| -Net Extraordinary Losses | - | - | - | - | ||||
| +Discounted operations | - | - | - | - | ||||
| +XO & Accounting Changes | - | - | - | - | ||||
| Income Incl. MI | 0.1 | -0.5 | 9.7 | 15.7 | ||||
| -Minority Interests | -0.0 | 0.1 | -0.2 | -0.0 | ||||
| Net Income, GAAP | 0.1 | -0.5 | 9.9 | 15.7 | ||||
| -Prfrrd Div & Other | - | - | - | - | ||||
| Net Income Avail To Common | 0.1 | -0.5 | 9.9 | 15.7 | ||||
| Weighted Average Shs Out | 262,189 | 588,235 | 588,235 | 1,700,848 | ||||
| EPS | 12.4 | -22.3 | 16.8 | 54.7 | ||||
| Weighted Average Shs Out Dil | 262,189 | 588,235 | 588,235 | 1,700,848 | ||||
| EPS Diluted | 12.4 | -22.3 | 16.8 | 54.7 | ||||
| Millions USD (ex. Per Share) | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M09/30/2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.1 | 5.4 | 4.7 | 5.5 | ||||
| -Cost of Revenue | 3.5 | 3.6 | 3.8 | 4.0 | ||||
| Gross Profit | 1.7 | 1.8 | 1.0 | 1.5 | ||||
| -Operating Expenses | 1.6 | 3.0 | 11.7 | 6.0 | ||||
| +Selling, General & Admin | 1.6 | 3.0 | 11.7 | 6.0 | ||||
| +General And Administrative Expenses | 1.6 | 2.8 | 10.5 | 4.4 | ||||
| +Selling And Marketing Expenses | 0.0 | 0.2 | 1.2 | 0.3 | ||||
| +Research and Development | - | - | - | - | ||||
| +Other Operating Expenses | - | - | - | - | ||||
| Operating Income | 0.0 | -1.2 | -10.7 | -4.7 | ||||
| +Non Operating Income | 0.0 | -0.6 | 19.8 | 19.1 | ||||
| +Interest Income, Net | -0.0 | -0.8 | -0.6 | -0.7 | ||||
| +Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | ||||
| -Interest Expense | 0.0 | 0.8 | 0.6 | 0.7 | ||||
| +Other Non-Op Income | 0.1 | 0.2 | 20.5 | 19.9 | ||||
| Pretax Income | 0.1 | -1.0 | 9.7 | 15.2 | ||||
| -Income Tax Expense | - | -0.5 | - | -0.5 | ||||
| Income from Cont Ops | 0.1 | -0.5 | 9.7 | 15.7 | ||||
| -Net Extraordinary Losses | - | - | - | - | ||||
| +Discounted operations | - | - | - | - | ||||
| +XO & Accounting Changes | - | - | - | - | ||||
| Income Incl. MI | 0.1 | -0.5 | 9.7 | 15.7 | ||||
| -Minority Interests | -0.0 | 0.1 | -0.2 | -0.0 | ||||
| Net Income, GAAP | 0.1 | -0.5 | 9.9 | 15.7 | ||||
| -Prfrrd Div & Other | - | - | - | - | ||||
| Net Income Avail To Common | 0.1 | -0.5 | 9.9 | 15.7 | ||||
| Weighted Average Shs Out | 262,189 | 588,235 | 588,235 | 1,700,848 | ||||
| EPS | 12.4 | -22.3 | 16.8 | 54.7 | ||||
| Weighted Average Shs Out Dil | 262,189 | 588,235 | 588,235 | 1,700,848 | ||||
| EPS Diluted | 12.4 | -22.3 | 16.8 | 54.7 | ||||